Venture capital for companies developing innovative therapeutics

Our Team

We are driven by the quest for new and better medicines.

Innovative Drug Development

Be invested in an attractive growth market.

BB Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats.

BB Pureos Bioventures strives to impact patients’ lives by advancing innovative treatments for severe diseases.

We are driven by the quest for new and better medicines

Our Portfolio

Our companies develop innovative medicines.

Latest News

We are happy to share our latest progress.

November 2020

AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury

November 2020

ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01

November 2020

Pureos Bioventures invests in seed financing of Corlieve Therapeutics SAS to develop therapies for severe neurological conditions

Member of